Remission of intestinal Behcet's disease treated with anti-tumor necrosis factor alpha monoclonal antibody (Infliximab)
The Korean Journal of Internal Medicine
;
: 24-27, 2007.
Article
Dans Anglais
| WPRIM
| ID: wpr-199149
ABSTRACT
Behcet's disease (BD) is a chronic relapsing multisystem disease characterized by oral ulceration, genital ulceration and ocular lesions. Gastrointestinal involvement is rare, often difficult to treat and associated with a high mortality rate. We treated a 47-year-old Korean man with BD who had a recurrent intestinal ulcer with tumor necrosis factor alpha antibody (infliximab); he initially underwent right hemicolectomy due to uncontrolled intestinal bleeding. For patients with intestinal BD who fail to respond to conventional treatment, infliximab may be a safe and effective new therapeutic option.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Induction de rémission
/
Agents gastro-intestinaux
/
Maladie de Behçet
/
Facteur de nécrose tumorale alpha
/
Résultat thérapeutique
/
Colectomie
/
Évolution de la maladie
/
Maladies gastro-intestinales
/
Anticorps monoclonaux
Limites du sujet:
Humains
/
Mâle
langue:
Anglais
Texte intégral:
The Korean Journal of Internal Medicine
Année:
2007
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS